SEC 13F Intelligence

Handelsbanken Fonder AB / ABT

Handelsbanken Fonder AB’s Abbott Laboratories Position

Does Handelsbanken Fonder AB own Abbott Laboratories (ABT)? Yes — 1.18M shares worth $121M (+0.40% of its 13F portfolio) as of Q1 2026, down from 1.22M shares the prior filed quarter.

Position Value
$121M
Q1 2026
Shares
1.18M
% of Portfolio
+0.40%
Quarters Held
29
currently held

Position History ABT

Reported value by quarter
Q1 ’19: $75MQ1 ’19Q2 ’19: $87MQ3 ’19: $95MQ4 ’19: $99MQ1 ’20: $87MQ1 ’20Q2 ’20: $268MQ3 ’20: $170MQ4 ’20: $171MQ1 ’21: $210MQ1 ’21Q2 ’21: $200MQ3 ’21: $209MQ4 ’21: $232MQ1 ’22: $195MQ1 ’22Q2 ’22: $186MQ3 ’22: $174MQ4 ’22: $194MQ1 ’23: $184MQ1 ’23Q2 ’23: $196MQ3 ’23: $174MQ4 ’23: $225MQ1 ’24: $225MQ1 ’24Q2 ’24: $168MQ3 ’24: $193MQ4 ’24: $152MQ1 ’25: $174MQ1 ’25Q2 ’25: $148MQ3 ’25: $147MQ4 ’25: $153MQ1 ’26: $121MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 20261.18M$121M+0.40%
Q4 20251.22M$153M+0.46%
Q3 20251.10M$147M+0.47%
Q2 20251.09M$148M+0.53%
Q1 20251.31M$174M+0.72%
Q4 20241.34M$152M+0.58%
Q3 20241.69M$193M+0.76%
Q2 20241.62M$168M+0.73%
Q1 20241.98M$225M+0.97%
Q4 20232.04M$225M+1.09%
Q3 20231.80M$174M+0.97%
Q2 20231.79M$196M+1.05%
Q1 20231.81M$184M+1.06%
Q4 20221.77M$194M+1.22%
Q3 20221.79M$174M+1.16%
Q2 20221.71M$186M+1.21%
Q1 20221.65M$195M+1.09%
Q4 20211.65M$232M+1.14%
Q3 20211.77M$209M+1.09%
Q2 20211.72M$200M+1.04%
Q1 20211.76M$210M+1.19%
Q4 20201.56M$171M+1.04%
Q3 20201.56M$170M+1.24%
Q2 20202.93M$268M+1.14%
Q1 20201.10M$87M+1.88%
Q4 20191.14M$99M+1.71%
Q3 20191.13M$95M+1.91%
Q2 20191.03M$87M+1.61%
Q1 2019942.2K$75M+1.46%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Handelsbanken Fonder AB’s full portfolio or all institutional holders of ABT.